RenovoRx, Inc. — Investor Relations & Filings
Filings indexed
260
across all filing types
Latest filing
2026-05-15
Annual Report
Country
US
United States of America
Listing
US
RNXT
RenovoRx, Inc. is a clinical-stage life sciences company developing targeted oncology therapies for solid tumors. The company's core technology is its proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform, which is designed for the localized delivery of therapeutic agents directly to tumors. This approach aims to enhance treatment efficacy while minimizing the systemic toxicities associated with conventional intravenous chemotherapy. The TAMP platform is enabled by the RenovoCath®, an FDA-cleared dual-balloon infusion catheter that isolates blood flow for targeted drug delivery. RenovoRx is advancing its lead drug-device combination product candidate in the Phase III TIGeR-PaC clinical trial for the treatment of locally advanced pancreatic cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K/A | 2026-05-15 | English | |
| 8-K | 2026-05-14 | English | |
| DEF 14A - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-30 | English | |
| 424B3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-27 | English | |
| S-3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-16 | English | |
| 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46363239 | 10-K/A | 2026-05-15 | English | ||
| 46274549 | 8-K | 2026-05-14 | English | ||
| 39207996 | DEF 14A - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-30 | English | ||
| 37646430 | 424B3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-27 | English | ||
| 34650376 | S-3 - RenovoRx, Inc. (0001574094) (Filer) | 2026-04-16 | English | ||
| 33058807 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English | ||
| 33058608 | 3/A - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-27 | English | ||
| 33058261 | 8-K - RenovoRx, Inc. (0001574094) (Filer) | 2026-03-27 | English | ||
| 33036308 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036307 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036306 | 4 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33036294 | 3 - RenovoRx, Inc. (0001574094) (Issuer) | 2026-03-25 | English | ||
| 33012729 | 8-K - RenovoRx, Inc. (0001574094) (Filer) | 2026-03-23 | English | ||
| 30649394 | 8-K Filing | 2026-02-06 | English | ||
| 30649391 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
RenovoRx, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34656/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34656 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34656 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34656 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34656}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RenovoRx, Inc. (id: 34656)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.